novosorb biodegradable temporising matrix

  1. 20,536 Posts.
    lightbulb Created with Sketch. 1835
    both of these trial should now have their first patients enrolled, that's if they stick to their timetable?

    http://www.anzctr.org.au/trial_view.aspx?id=343134

    Request Number: 343134
    ACTR Number: ACTRN12611000753954
    Trial Status: Registered
    Date Submitted: 29/06/2011
    Date Registered: 18/07/2011
    Date Last Updated: 18/07/2011
    Registration Type: Prospective
    Page 1
    Public title: Repairing a deep donor site using a new, dissolvable, plastic scaffold.
    Update:

    Reason:
    ANZCTR registration title: An evaluation of function and appearance following reconstruction of a free-flap donor site after biodegradable polymer implant incorporation and secondary split skin grafting.

    Anticipated or actual date of first participant enrolement: 1/10/2011
    Update:

    Reason:
    Target sample size: 10

    -----------------------------------------------------------

    http://www.anzctr.org.au/trial_view.aspx?id=343132

    Request Number: 343132
    ACTR Number: ACTRN12611000815965
    Trial Status: Registered
    Date Submitted: 29/06/2011
    Date Registered: 3/08/2011
    Date Last Updated: 03/08/2011
    Registration Type: Prospective
    Page 1
    Public title: Using a biodegradable polyurethane foam in comparison with Granufoam (black, non-biodegradable foam) with Vacuum-Assisted Closure in the management of decubitus ulcers (pressure sores)
    Update:

    Reason:
    ANZCTR registration title: Safety and efficacy of vacuum assisted closure with a biodegradable polyurethane foam versus Granufoam in pressure sore sufferers.

    Anticipated or actual date of first participant enrolement: 1/09/2011
    Update:

    Reason:
    Target sample size: 20
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.